Pacer Advisors, Inc. Novavax Inc Transaction History

Pacer Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.89 - $20.97 $24,658 - $132,928	-6,339 Reduced 80.98%	1,489 $18,000
Q1 2024 May 10, 2024	BUY	$3.76 - $6.02 $29,433 - $47,124	7,828 New	7,828 $37,000
Q2 2021 Jul 21, 2021	SELL	$121.0 - $257.67 $45,980 - $97,914	-380 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$112.98 - $319.93 $75,244 - $213,073	-666 Reduced 63.67%	380 $69,000
Q4 2020 Jan 20, 2021	SELL	$78.74 - $139.5 $99,212 - $175,770	-1,260 Reduced 54.64%	1,046 $117,000
Q3 2020 Oct 19, 2020	BUY	$79.44 - $178.51 $183,188 - $411,644	2,306 New	2,306 $250,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.